![Victoria Vakiener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victoria Vakiener
Director/Board Member at
ARROWHEAD PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2026-07-30
Profile
Victoria Vakiener is an Independent Director at Arrowhead Pharmaceuticals, Inc. since 2022.
Former roles include Independent Director at Chimerix, Inc. from 2021 to 2025, Vice President at Janssen Pharmaceuticals, Inc. from 2018 to 2020, Chief Commercial Officer at Epizyme, Inc. from 2020 to 2021, and Vice President-Oncology Marketing at Janssen Oncology, Inc. from 2014 to 2018.
Education includes undergraduate studies at Albright College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-14 | 35,723 ( 0.03% ) | 3 M $ | 2026-07-30 |
Victoria Vakiener active positions
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2022-05-01 |
Former positions of Victoria Vakiener
| Companies | Position | End |
|---|---|---|
| CHIMERIX, INC. | Director/Board Member | 2025-04-20 |
| EPIZYME, INC. | Corporate Officer/Principal | 2021-09-30 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 2020-08-31 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 2018-11-30 |
Training of Victoria Vakiener
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Albright College
 Albright College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Victoria Vakiener
